Balsalazide Oral Capsule 750Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Balsalazide: Oral capsule (750mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_10197.JPG
Balsalazide 750mg Cap
Roxane Laboratories Inc
Pill Identification: 54 795 54 795 

What is this Medicine?

BALSALAZIDE (bal SAL a zide) is used to treat the pain and inflammation caused by ulcerative colitis.

Similar Brand Name Drugs : Colazal: Oral capsule (750mg)
CVS Pharmacy Patient Statistics for Balsalazide: Oral capsule(750mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Balsalazide Disodium 750mg Capsule

NDC: 000540079
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Ulcerative Colitis

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Balsalazide Disodium 750mg Capsule
Drug Image file DrugItem_10197.JPG
Roxane Laboratories Inc
Pill Identification: 54 795 54 795 
Shape: capsule
Color: orange

Reported Side Effects for Balsalazide Disodium 750mg Capsule

Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
<4.0%*
Severity: MILD
Onset: DELAYED
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Rhinitis Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Intestinal Bleeding Incidence:
1.0-2.0%*
Severity: SEVERE
Onset: DELAYED
Dry Mouth Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Muscle Pain Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
8.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Balsalazide

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5